Results 211 to 220 of about 38,122 (350)

Assessment of anxiety and health-related quality of life in patients with lower extremity peripheral arterial occlusive disease. [PDF]

Arch Med Sci Atheroscler Dis, 2020
Guzelhan Y, Oztas DM, Conkbayir C, Rodoplu O, Erdinc I, Canbay C, Ugurlucan M, Alpagut U, Bozbuga N.   +8 more
europepmc   +1 more source

The Hemobahn endoprosthesis: A self-expanding polytetrafluoroethylene-covered endoprosthesis for the treatment of peripheral arterial occlusive disease after balloon angioplasty

, 2001
Brian G. Rubin, Gregorio A. Sicard
openalex   +1 more source

Blood Oxygenation Level–Dependent Magnetic Resonance Imaging of the Skeletal Muscle in Patients With Peripheral Arterial Occlusive Disease [PDF]

, 2006
Hans Peter Ledermann, Anja‐Carina Schulte, Hanns‐Georg Heidecker, Markus Aschwanden, Kurt Jäger, Klaus Scheffler, W. Steinbrich, Deniz Bilecen   +7 more
openalex   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, EarlyView.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

Editor's Choice - International Variations and Sex Disparities in the Treatment of Peripheral Arterial Occlusive Disease: A Report from VASCUNET and the International Consortium of Vascular Registries. [PDF]

Eur J Vasc Endovasc Surg, 2020
Behrendt CA, Sigvant B, Kuchenbecker J, Grima MJ, Schermerhorn M, Thomson IA, Altreuther M, Setacci C, Svetlikov A, Laxdal EH, Goncalves FB, Secemsky EA, Debus ES, Cassar K, Beiles B, Beck AW, Mani K, Bertges D.   +17 more
europepmc   +1 more source

Fibrinogen Apheresis and peripheral vascular disease: Some progress? [PDF]

, 2007
Schiffl, Helmut
core   +2 more sources

Treating cellulitis promptly with compression therapy reduces C‐reactive protein‐levels and symptoms – a randomized‐controlled trial

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Cellulitis is an acute bacterial infection of the skin. Initial treatment primarily consists of systemic antibiotic therapy. Compression therapy is subsequently introduced to reduce edema. However, the optimal timing for initiating compression therapy remains a subject of debate, as early application is thought to ...
Sören Dräger, Charlotte Kiehne, Greta Zinser, Birgit Kahle   +3 more
wiley   +1 more source

[What is new in the management of peripheral arterial occlusive disease and diseases of the aorta? : Highlights of the ESC guidelines 2024]. [PDF]

Herz
Schulze-Bauer H, Staudacher M, Steiner S, Schlager O.   +3 more
europepmc   +1 more source

Peripheral Arterial Occlusive Disease Is More Prevalent in Patients With Hemodialysis: Comparison With the Findings of Multidetector-Row Computed Tomography [PDF]

, 2006
Koji Okamoto, Machiko Oka, Kyoko Maesato, Ryota Ikee, Tsutomu Mano, Hidekazu Moriya, Takayasu Ohtake, Shuzo Kobayashi   +7 more
openalex   +1 more source

Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate whether initiating sodium‐glucose cotransporter 2 inhibitors (SGLT2i) within 3 months after a urinary tract infection (UTI) is associated with improved long‐term outcomes in patients with type 2 diabetes mellitus (T2DM), compared with dipeptidyl peptidase‐4 inhibitors (DPP‐4i).
Hsiao‐Wei Wang, Ming‐Hsien Tsai, Yu‐Wei Fang, Kuo‐Cheng Lu, Joshua Wang, Chien‐Lin Lu   +5 more
wiley   +1 more source